FOLD Q1 2022 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

FOLDAmicus Therapeutics, Inc.

$5B

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$79M+18.5% YoY

Gross Profit

$71M90.4% margin

Operating Income

-$75M-95.7% margin

Net Income

-$85M-108.3% margin

EPS (Diluted)

$-0.30

QoQ Revenue Growth

-4.2%

Cash Flow

Operating Cash Flow

-$58M

Free Cash Flow

-$59M

Stock-Based Comp.

$31M

Balance Sheet

Total Assets

$827M

Total Liabilities

$588M

Stockholders' Equity

$239M

Cash & Equivalents

$233M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$79M	$66M	+18.5%
Gross Profit	$71M	$60M	+18.8%
Operating Income	-$75M	-$53M	-42.0%
Net Income	-$85M	-$66M	-29.8%

Geographic Segments

Non-US

$55M69%

UNITED STATES

$24M31%